Dr. Barr On Temozolomide And Capecitabine In Neuroendocrine Tumors

Dr. Barr on Temozolomide and Capecitabine in Neuroendocrine Tumors

Dr. Robert Fine on Capecitabine Plus Temozolomide for Neuroendocrine Tumors

Dr. Barr on Systemic Therapies for Patients With Neuroendocrine Tumors

NETs: Capecitabine plus temozolomide gives longer PFS than temozolomide alone

Dr. Krishnamurthi on CAPTEM as Treatment for Neuroendocrine Tumors

Dr. Helft on the CAPTEM Regimen in Patients With Neuroendocrine Tumors

Dr. Fine on the Utility of CAPTEM in Chemo-Resistant Neuroendocrine Tumors

Targeted Oncology

Dr. Iqbal on the Biggest Advance in the Treatment of Neuroendocrine Tumors

ECOG-ACRIN E2211: MGMT predictive of response to temozolomide in advanced pancreatic NETs

Dr. Chan Discusses Cabozantinib for the Treatment of NETs

Targeted Oncology

Alkylating Agents in Pancreatic Neuroendocrine Tumors

Chemotherapy in Neuroendocrine Tumors (NETs)

Dr. Primrose on Adjuvant Capecitabine For Biliary Tract Cancer

CAPPTEM Chemo - Pamela Kunz

Dr. Anders Discusses the Use of Neratinib/Capecitabine for HER2-Positive Brain Metastases

Dr. Toms on NovoTTF and Temozolomide for Glioblastoma

Targeted Oncology

The Genetics Behind Familial Neuroendocrine Tumors

Combining PRRT with Targeted Therapy

Dr. Chan on Trial of Cabozantinib in Neuroendocrine Tumors

Olaparib and temozolomide for relapsed small cell lung cancer